Skip to main content
Clinical Trials/NCT05334966
NCT05334966
Active, not recruiting
Not Applicable

Evaluation of the Use of Supplemental Oxygen to Mothers With Fetal Left Heart Hypoplasia

Baylor College of Medicine1 site in 1 country25 target enrollmentJanuary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Left Heart Hypoplasia
Sponsor
Baylor College of Medicine
Enrollment
25
Locations
1
Primary Endpoint
Aortic annular dimension
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Heart disease is the leading cause of infant death related to birth defects. Congenital heart disease in which the left sided structures of the heart (left heart hypoplasia or LHH) are too small are among the most severe, and have some of the highest death and other complication rates.

Detailed Description

We intend to study a new, non-invasive fetal intervention to help outcomes in children with LHH. We plan to study the effect of giving oxygen to mothers who have fetuses with small left-sided structures. We specifically will evaluate if the fetal left heart valves will grow faster if the mother breathes extra oxygen on a daily basis (at least 8 hours per day). Mothers and fetuses meeting criteria will be offered to enroll in the study. All enrolled mothers will be asked to receive oxygen continuously for the rest of the pregnancy using a non-rebreather mask. At birth, we will compare the fetuses whose mothers received oxygen to historical controls. We specifically will study how fast the left heart valves have grown.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
December 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shaine Morris

Associate Professor

Baylor College of Medicine

Eligibility Criteria

Inclusion Criteria

  • Group A, C: Fetuses with hypoplastic left sided structures or at risk of coarctation of the aorta and ALL of the following
  • Any mitral annulus, aortic annulus, left ventricular end-diastolic dimension, or aortic diameter z-score less than or equal to 3.0
  • Right-left ventricular size discrepancy with no other explanation of discrepancy
  • Retrograde blood flow in the aortic arch from the ductus arteriosus
  • Left to right flow across the foramen ovale
  • Group B: Healthy Fetal controls
  • Mothers undergoing screening fetal echo for family history of CHD with a normal echo.
  • Mothers undergoing fetal echocardiography for suspected heart disease with a normal echo
  • Mothers evaluated in the fetal center with normal ultrasound
  • Fetuses with hypoplastic left sided structures or at risk of coarctation of the aorta and any of the following

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Aortic annular dimension

Time Frame: 2 years

By fetal echo the size of the aortic annulus in mm

Secondary Outcomes

  • Mitral annular dimension(years)

Study Sites (1)

Loading locations...

Similar Trials